The Liquid Biopsy Accelerator Grant

Our mission is to drive innovation by providing resources and tools researchers and clinicians need to catalyze scientific progress that helps make the world safer, healthier and more productive.

The Liquid Biopsy Accelerator Grant provides funding for research that relies upon Streck stabilization products. Awardees are expected to be from academic laboratories and companies with research focused on non-invasive early detection strategies (i.e., liquid biopsy). Priority will be given to applicants who demonstrate dedication to their scientific work and provide proposals that align with the mission of the grant — particularly those offering innovative contributions to the field.

The Liquid Biopsy Accelerator Grant will be awarded to five applicants. Each will receive a product credit of $2,500 USD. One applicant will be selected as the grand prize winner and will receive an additional $7,500 USD credit, applicable to any of Streck’s products. The grand prize winner will also be sponsored by Streck to attend AACR 2026 or another relevant U.S. conference and will be invited to collaborate on a poster presentation and other scientific engagements in support of the grant.

Awardees will be expected to provide a quarterly progress update, and awardees will be encouraged to engage with Streck scientists in troubleshooting and data interpretation needs.

All proposals are due no later than 11:59 p.m. CST on August 31, 2025. Applicants will receive notice on the status of their selection no later than November 12, 2025.

• Entries must be completed and submitted in English.
• Incomplete applications will not be considered.
• Official organizational email and mailing address must be used for the application.
• Applicants must acknowledge the grant and cite Streck products or services received.
• Awardees should be prepared to share their research with both the Streck research community and the broader scientific community.
• Awardees have one year from the award date to redeem their prize.
• Open to domestic U.S. applicants only.